1-Minute quality control tests for positron emission tomography radiopharmaceuticals

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 2, 2009, Pages 245-251

  Nakao, Ryuji ^a   Ito, Takehito ^a,b   Hayashi, Kazutaka ^a   Fukumura, Toshimitsu ^a   Yamaguchi, Masatoshi ^c   Suzuki, Kazutoshi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b Sumitomo Accelerator Service   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

Chemical impurity; PET radiopharmaceuticals; Quality control; Specific radioactivity; Ultra fast LC

Indexed keywords

3 METHYLSPIPERONE C 11; 5R3B C 11; ACL703 C 11; CARBON 11; CIANOPRAMINE C 11; DAA1106 C 11; DASB C 11; DEXTRO NNC112 C 11; EMAPUNIL C 11; FETDAA1106 F 18; FLUMAZENIL C 11; FMENER D2 F 18; FMT F 18; GEFITINIB C 11; ISOREMOXIPRIDE C 11; LEVODOPA C 11; MCN5652X C 11; METHIONINE C 11; MNPA C 11; MP4A C 11; MP4P C 11; NMPB C 11; PE21 C 11; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; RO15 4513 C 11; SCH23390 C 11; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL C 11; WAY100635 C 11;

ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; LIQUID CHROMATOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; RADIOACTIVITY; RADIOCHEMISTRY; SCINTILLATION; SENSITIVITY ANALYSIS; ULTRAVIOLET SPECTROSCOPY; VALIDATION STUDY;

POSITRON-EMISSION TOMOGRAPHY; QUALITY CONTROL; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS;

EID: 67349252264     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.04.016     Document Type: Article

References (14)

1. The United States Pharmacopeia, 31st ed., and The National Formulary, 26th ed., Rockville, MD, United States Pharmacopeial Convention, 2008, pp. 1639-1642, 2192-2193.
2. The European Pharmacopeia, 6th ed., Strasbourg, France: European Directorate for the Quality of the Medicines, 2008, pp. 986-990, 1001-1003, 1005-1006.
3. MacNair J.E., Lewis K.C., and Jorgenson J.W. Anal. Chem. 69 (1997) 983-989
4. Plumb R.S., Granger J.H., Stumpf C.L., Johnson K.A., Smith B.W., Gaulitz S., Wilson I.D., and Castro-Perez J. Analyst 130 (2005) 844-849
5. Dejaegher B., and Heyden Y.V. J. Chromatogr. A 1158 (2007) 138-157
6. Wilson I.D., Plumb R., Granger J., Major H., Williams R., and Lenz E.M. J. Chromatogr. B 817 (2005) 67-76
7. Fukumura T., Suzuki H., Mukai K., Zhang M.R., Yoshida Y., Nemoto K., and Suzuki K. J. Labelled Compd. Radiopharm. 50 (2007) S202
8. Namba H., Iyo M., Fukushi K., Shinotoh H., Nagatsuka S., Suhara T., Sudo Y., Suzuki K., and Irie T. Eur. J. Nucl. Med. 26 (1999) 135-143
9. Wyndham K.D., O'Gara J.E., Walter T.H., Glose K.H., Lawrence N.L., Alden B.A., Izzo G.S., Hudalla C.J., and Iraneta P.C. Anal. Chem. 75 (2003) 6781-6788
10. The United States Pharmacopeia, 31st ed., and The National Formulary, 26th ed., Rockville, MD, United States Pharmacopeial Convention, 2008, pp. 232-243.
11. Shields A.F., Grierson J.R., Dohmen B.M., Machulla H.J., Stayanoff J.C., Lawhorn-Crews J.M., Obradovich J.E., Muzik O., and Mangner T.J. Nat. Med. 4 (1998) 1334-1336
12. Buck A.K., Halter G., Schirrmeister H., Kotzerke J., Wurziger I., Glatting G., Mattfeldt T., Neumaier B., Reske S.N., and Hetzel M. J. Nucl. Med. 44 (2003) 1426-1431
13. Martin S.J., Eisenbarth J.A., Wagner-Utermann U., Mier W., Henze M., Pritzkow H., Haberkorn U., and Eisenhut M. Nucl. Med. Biol. 29 (2002) 263-273
14. Nakao R., Ito T., Yamaguchi M., and Suzuki K. Nucl. Med. Biol. 35 (2008) 239-244